CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  He, Songbing ^a   Wang, Liang ^a   Wu, Yugang ^b   Li, Dechun ^a   Zhang, Yanyun ^c  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL3 CHEMOKINE; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MELANOMA ANTIGEN 1; CANCER VACCINE; CCL20 PROTEIN, HUMAN; CCL3 PROTEIN, HUMAN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAGEA1 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CELL CULTURE; CELL ISOLATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSDUCTION; IN VITRO STUDY; IN VIVO STUDY; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR IMMUNITY; VACCINATION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CARCINOMA; HUMAN; LUNG; METABOLISM; METASTASIS; PATHOLOGY; STOMACH TUMOR; T LYMPHOCYTE;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CARCINOMA; CHEMOKINE CCL20; CHEMOKINE CCL3; DENDRITIC CELLS; FEMALE; HUMANS; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASM PROTEINS; STOMACH NEOPLASMS; T-LYMPHOCYTES;

EID: 77951250756     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-37     Document Type: Article

References (22)

1. Gastric cancer. Hohenberger P, Gretschel S, Lancet 2003 362 305 15 10.1016/S0140-6736(03)13975-X 12892963 (Pubitemid 36936845)
2. Gastric cancer: surgical treatment and prognostic score. Guida F, Formisano G, Esposito D, Antonino A, Conte P, Bencivenga M, Persico M, Avallone U, Minerva Chir 2008 63 93 9 18427441
3. Stage-specific guided adjuvant treatment for gastric cancer. Liakakos T, Fatourou E, Ann Surg Oncol 2008 15 2622 3 10.1245/s10434-008-9913-2 18431608
4. DC-based cancer vaccines. Gilboa E, J Clin Invest 2007 117 1195 203 10.1172/JCI31205 17476349 (Pubitemid 46718404)
5. Dendritic cells and the control of immunity. Banchereau J, Steinman RM, Nature 1998 392 245 52 10.1038/32588 9521319 (Pubitemid 28155090)
6. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1 in mice. Zhang Y, Yoneyama H, Wang Y, Ishikawa S, Hashimoto S, Gao JL, Murphy P, Matsushima K, J Natl Cancer Inst 2004 96 201 9 10.1093/jnci/djh024 14759987 (Pubitemid 38263179)
7. MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood. He S, Cao Q, Yoneyama H, Ge H, Zhang Y, Zhang Y, J Leukoc Biol 2008 84 1549 56 10.1189/jlb.0708420 18791167 (Pubitemid 352774490)
8. Bone marrow-derived dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric cancer ex vivo. Li YL, Wu YG, Wang YQ, Li Z, Wang RC, Wang L, Zhang YY, World J Gastroenterol 2008 14 7127 32 10.3748/wjg.14.7127 19084922
9. Dendritic cell based tumor vaccines. Nouri-Shirazi M, Banchereau J, Fay J, Palucka K, Immunology letters 2000 74 5 10 10.1016/S0165-2478(00)00243-1 10996622
10. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Bruggen P Van der, Traversari C, Chomez P, Lurquin C, De Plaen E, Eynde B Van den, Knuth A, Boon T, Science 1991 254 1643 7 10.1126/science.1840703 1840703 (Pubitemid 21917508)
11. Human tumor rejection antigens MAGE. Itoh K, Hayashi A, Nakao M, Hoshino T, Seki N, Shichijo S, J Biochem 1996 119 385 90 8830028 (Pubitemid 26100920)
12. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Lucas S, De Smet C, Arden KC, Viars CS, Lethé B, Lurquin C, Boon T, Cancer Res 1998 58 743 52 9485030 (Pubitemid 28099487)
13. Induction of dendritic cell differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor, and tumor necrosis factor in vitro from lineage phenotypes-negative c-kit murine hematopoietic progenitor cells. Zhang Y, Mukaida N, Wang J, Harada A, Akiyama M, Matsushima K, Blood 1997 90 4842 53 9389701 (Pubitemid 28007198)
14. Immunobiology of Dendric cells. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K, Annu Rev Immunol 2000 18 767 811 10.1146/annurev.immunol.18.1.767 10837075 (Pubitemid 30365397)
15. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. Klein C, Bueler H, Mulligan RC, J Exp Med 2000 191 1699 1708 10.1084/jem.191.10.1699 10811863 (Pubitemid 30331568)
16. Exploiting dendritic cells to improve vaccine efficacy. Steinman RM, Pope M, J Clin Invest 2002 109 1519 26 12070296 (Pubitemid 34663511)
17. Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer. Kono K, Takahashi A, Sugai H, Fujii H, Choudhury AR, Kiessling R, Matsumoto Y, Clin Cancer Res 2002 8 3394 3400 12429626 (Pubitemid 35340713)
18. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Sallusto F, Lanzavecchia A, Immunol Rev 2000 177 134 40 10.1034/j.1600-065X.2000.17717.x 11138771
19. The role of chemokines in. Wada T, Matsushima K, Kaneko S
20. The role of chemokines and their receptors in dendritic cell biology. Lukacs-Kornek V, Engel D, Tacke F, Kurts C, Front Biosci 2008 13 2238 52 10.2741/2838 17981706 (Pubitemid 351589249)
21. Dendritic cells in cancer immunotherapy. Fong L, Engleman EG, Annu Rev Immunol 2000 18 245 73 10.1146/annurev.immunol.18.1.245 10837059 (Pubitemid 30365381)
22. New serotypes of adenoviral vectors. Stone D, Lieber A, Curr Opin Mol Ther 2006 8 423 31 17078384 (Pubitemid 44566783)